Published online 19 February 2009
Haematologica, Vol 94, Issue 4, 462-469 doi:10.3324/haematol.13728
Copyright © 2009 by Ferrata Storti Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Orelio et al. - Supplementary Appendix
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Orelio, C.
Right arrow Articles by Dzierzak, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Orelio, C.
Right arrow Articles by Dzierzak, E.

Hematopoietic Stem Cells

Interleukin-1 regulates hematopoietic progenitor and stem cells in the midgestation mouse fetal liver

Claudia Orelio, Marian Peeters, Esther Haak, Karin van der Horn, Elaine Dzierzak

Erasmus University Medical Center, Department of Cell Biology and Genetics, Rotterdam, The Netherlands

Correspondence: Elaine Dzierzak, Erasmus University Medical Centre, Dept. of Cell Biology and Genetics, P.O. Box 2040 3000 CA Rotterdam, The Netherlands. E-mail:e.dzierzak{at}erasmusmc.nl

Background: Hematopoietic progenitors are generated in the yolk sac and aorta-gonad-mesonephros region during early mouse development. At embryonic day 10.5 the first hematopoietic stem cells emerge in the aorta-gonad-mesonephros. Subsequently, hematopoietic stem cells and progenitors are found in the fetal liver. The fetal liver is a potent hematopoietic site, playing an important role in the expansion and differentiation of hematopoietic progenitors and hematopoietic stem cells. However, little is known concerning the regulation of fetal liver hematopoietic stem cells. In particular, the role of cytokines such as interleukin-1 in the regulation of hematopoietic stem cells in the embryo has been largely unexplored. Recently, we observed that the adult pro-inflammatory cytokine interleukin-1 is involved in regulating aorta-gonad-mesonephros hematopoietic progenitor and hematopoietic stem cell activity. Therefore, we set out to investigate whether interleukin-1 also plays a role in regulating fetal liver progenitor cells and hematopoietic stem cells.

Design and Methods: We examined the interleukin-1 ligand and receptor expression pattern in the fetal liver. The effects of interleukin-1 on hematopoietic progenitor cells and hematopoietic stem cells were studied by FACS and transplantation analyses of fetal liver explants, and in vivo effects on hematopoietic stem cell and progenitors were studied in Il1r1–/– embryos.

Results: We show that fetal liver hematopoietic progenitor cells express the IL-1RI and that interleukin-1 increases fetal liver hematopoiesis, progenitor cell activity and promotes hematopoietic cell survival. Moreover, we show that in Il1r1–/– embryos, hematopoietic stem cell activity is impaired and myeloid progenitor activity is increased.

Conclusions: The IL-1 ligand and receptor are expressed in the midgestation liver and act in the physiological regulation of fetal liver hematopoietic progenitor cells and hematopoietic stem cells.

Key words: Interleukin-1, hematopoiesis, hematopoietic stem cell, fetal liver, aorta-gonad-mesonephros.